Ikena Oncology Inc (IKNA) Stock
IKNA is no longer traded. Ikena Oncology was delisted from the Nasdaq in July 2025.
Prices on this page are historical; the last trade was July 25, 2025 at $17.16.
Ikena Oncology stock price history
IKNA final trading statistics
- Final close
- $17.16
- Final trading day
- Jul 25, 2025
- Market cap at delisting
- $718.82M
- Shares outstanding
- 41.89M
- Final 52-week range
- $0.97 – $17.76
- Avg. volume (final 3 mo.)
- 17,171
- All-time high (split-adj.)
- $384.00 · Mar 2021
- All-time low (split-adj.)
- $12.36 · Apr 2025
- Return since IPO
- -95.5%
- Beta
- 0.50
- Book value / share
- $28.82
- Price / book
- 0.60
Ikena Oncology annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2024 | $0.00 | -$49.2M | -$1.00 |
| FY2023 | $9.16M | -$68.2M | -$1.70 |
| FY2022 | $15.62M | -$68.8M | -$1.92 |
| FY2021 | $30.98M | -$34.1M | -$3.20 |
| FY2020 | $9.19M | -$44.3M | -$1.60 |
Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About Ikena Oncology Inc
Ikena Oncology, Inc., an oncology company, focuses on developing therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance. It develops IK-595, a molecular glue designed to trap MEK and RAF in an inactive complex. The company was incorporated in 2016 and is headquartered in Boston, Massachusetts. As of July 25, 2025, Ikena Oncology, Inc. was acquired by Inmagene Biopharmaceuticals Co. Ltd.
Ikena Oncology stock FAQ
What happened to Ikena Oncology stock?
Ikena Oncology stock was delisted from the Nasdaq. Its final close was $17.16 on July 25, 2025.
Is IKNA stock still trading?
No. IKNA was delisted from the Nasdaq in July 2025 and no longer trades on a U.S. exchange.
What was the last price of IKNA stock?
IKNA closed at $17.16 on its final trading day, July 25, 2025, for a market value of about $718.82M.
What were Ikena Oncology's revenue and earnings in its last full fiscal year?
Ikena Oncology reported revenue of $0.00 and net income of -$49.2M in fiscal 2024, its last full year as a public company.
When did Ikena Oncology go public?
Ikena Oncology Inc stock began trading on March 26, 2021.